Growth Innovation Leadership Council

Lithium (Li)-ion batteries are the most prevalent rechargeable batteries with applications across a wide range of industries such as consumer electronics, electric vehicles (EVs), and stationary energy storage. Their ubiquitous use is due to their many advantages, which include high energy density, low maintenance cost, long lifespan, and high voltage capacity.

Asia will continue to be a large and rapidly growing segment of diabetes care technologies. To be competitive and successful in the aggressive landscape with numerous large and startup companies, players will need large funds, a broad portfolio with desirable differentiators, and a strong distribution network. Low-cost products, subscription-based solutions, reimbursement policies, and training of patients and physicians will be required to promote the adoption among low-income and middle-income regions. Large players are very intent on tapping the large growth potential in Asia. Many global companies have set up local presence in Asian countries and local production through original equipment manufacturer (OEM) partners in the countries to bring down the cost of their solutions, and more companies are expected to follow.

While the diabetes epidemic seems to have peaked in some of the more developed states, most of the less developed states are still in the initial take-off phase. The prevalence of other cardiometabolic risk factors such as obesity, hypertension, and dyslipidaemia is uniformly high across the country, particularly in the urban areas. The focus should be on implementing interventions to minimize the progression of prediabetes to diabetes in states where the diabetes epidemic has yet to peak and providing optimal care to ensure comprehensive risk factor reduction in individuals with diabetes so as to prevent complications in those states where the epidemic has already stabilized. Thus, there are serious implications for the nation, warranting urgent state-specific policies and interventions to arrest the rapidly rising epidemic of metabolic NCDs in India.